HomeHBP • TSE
add
Helix Biopharma Corp.
Previous close
$0.21
Day range
$0.21 - $0.21
Year range
$0.15 - $0.26
Market cap
47.04M CAD
Avg Volume
12.38K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Oct 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.25M | -21.01% |
Net income | -1.25M | 21.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.25M | 21.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Oct 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.64M | -62.68% |
Total assets | 1.90M | -60.53% |
Total liabilities | 1.27M | -77.53% |
Total equity | 622.00K | — |
Shares outstanding | 216.67M | — |
Price to book | ∞ | — |
Return on assets | -214.09% | — |
Return on capital | 2,819.82% | — |
Cash Flow
Net change in cash
(CAD) | Oct 2023info | Y/Y change |
---|---|---|
Net income | -1.25M | 21.92% |
Cash from operations | -1.85M | -33.24% |
Cash from investing | -12.00K | -100.00% |
Cash from financing | 2.69M | 4.64% |
Net change in cash | 832.00K | -27.34% |
Free cash flow | -1.38M | -136.23% |
About
Founded
1995
Headquarters
Website
Employees
9